Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.58 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.49 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.49 |
| ▸ | ROCK2 | O75116 | 14/20 | 0.48 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.48 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14334921 | 0.84 | MKNK1 (0.54) | ROCK2MKNK1MKNK2 | |
| SCHEMBL23458839 | 0.84 | ROCK2 (0.53) | ROCK2MKNK1MKNK2 | |
| SCHEMBL29882509 | 0.81 | CHRNB2 (0.48) | IRAK4CHEK1KCNH2CHRNB2CHRNA4 | |
| SCHEMBL14334551 | 0.81 | IRAK4 (0.59) | IRAK4CHRNB2CHRNA4ROCK2PARP1 | |
| SCHEMBL14334257 | 0.80 | CHRNB2 (0.55) | IRAK4CHEK1KCNH2CHRNB2CHRNA4 | |
| SCHEMBL16759169 | 0.79 | KCNH2 (0.53) | IRAK4CHEK1KCNH2CHRNB2CHRNA4 | |
| SCHEMBL20646781 | 0.78 | RAB9A (0.48) | ROCK2 | |
| SCHEMBL20646783 | 0.78 | RAB9A (0.48) | ROCK2 | |
| SCHEMBL3675210 | 0.78 | ROCK2 (0.47) | ROCK2 | |
| SCHEMBL6012159 | 0.76 | ROCK2 (0.49) | ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012176123-A1 | 3 - IMIDAZOLYL- INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | NOVARTIS AG (CH) | 2012-12-27 | — | — | WO | disclosed |